|
2008 |
Acquisition of subsidiaries in Guilin with 2 state Category. One new medicines -
RHEG Eye drops and
RHEG Hudrogel |
| |
| 2007 |
Proprietary products Fuke Zaiqao Capsule, Fentarzhong® Nano Silva Anti-Inflammatory Gel were launched into the market. |
| |
| 2006 |
Acquisition of a technical know-how and granted an exclusive intellectual property right and national patent right of a State “category one new medicine” biological medicine, Human Nerve Growing Factor injection, an effective treatment for nerve system disease, in September 2006
Magic Series launched in the Hong Kong market in December 2006
Established a wholly-owned subsidiary in Korea in December 2006 for trademark and patent registration of the “Magic美即” brand and products in Korea, and also for formation of strategic alliances with renowned universities and research institutes |
| |
| 2005 |
Magic Series start strategic cooperation with leading distribution channels including Watsons, Carrefour and Wal-Mart in China since October 2005
Subscription of new shares and formation of strategic alliance with singapore-listed company Haw Par Corporation Ltd. in June 2005 |
| |
| 2004 |
Acquisition of Guangdong Qunhe Pharmaceutical Company Limited (廣東群禾藥業有限公司) in July 2004, which has favourable advantages at the sales of feminine medicinal healthcare products, coupled with its ownership of "Magic 美即" brand and a team of sales elite
Acquisition of Guiyang De Chang Xiang Pharmaceutical Company Limited (貴陽德昌祥藥業有限公司) in October 2004, which owns the classic Chinese gynecological recuperation product Fuke Zaizaowan (婦科再造丸) |
| |
| 2003 - 04 |
Distributors of the Company ranked Hua Han as one of the top 5 pharmaceutical companies specializing in gynecological medicines and feminine medicinal healthcare products in the PRC |
| |
| 2003 |
Acquisition of Chengdu Hechuang Pharmacy Company Limited (成都禾創藥業有限公司) in June 2003, which is engaged in the trading of pharmaceutical products, healthcare products, and medical appliances and equipments |
| |
| 2002 |
On December 10, Hua Han was listed
on the Main Board of the Stock Exchange of Hong Kong Limited
(Stock Code: 587)
IPO price: HK$0.77/share
Number of issued shares: 568 million |
| |
| 2000 |
On August 28, Hua Han was duly incorporated
in the Cayman Islands
Camptothecine Series, Jin Xi
Su and Qiang Xi (gynecological anti-tumour products) were
successfully launched into the market |
| |
| 1992 |
In July, Guizhou Hanfang Medicine Manufacture Company Limited was founded by Mr.
Zhang Peter Y., Mr. Xu Peng and Mr. Deng Jie
"Yeosure" Series
(gynecological anti-inflammatory products) pioneered the market
for feminine lotion used in hospitals |
